[PDF][PDF] Parkinson disease epidemiology, pathology, genetics, and pathophysiology

DK Simon, CM Tanner, P Brundin - Clinics in geriatric medicine, 2020 - Elsevier
SYNOPSIS (1 paragraph): Parkinson's disease (PD) is a complex age-related
neurodegenerative disease associated with dopamine deficiency and both motor and …

PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease

P Ge, VL Dawson, TM Dawson - Molecular neurodegeneration, 2020 - Springer
That certain cell types in the central nervous system are more likely to undergo
neurodegeneration in Parkinson's disease is a widely appreciated but poorly understood …

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

R Gordon, EA Albornoz, DC Christie… - Science translational …, 2018 - science.org
Parkinson's disease (PD) is characterized by a profound loss of dopaminergic neurons in
the substantia nigra, accompanied by chronic neuroinflammation, mitochondrial dysfunction …

Converging pathways in neurodegeneration, from genetics to mechanisms

L Gan, MR Cookson, L Petrucelli, AR La Spada - Nature neuroscience, 2018 - nature.com
Neurodegenerative diseases cause progressive loss of cognitive and/or motor function and
pose major challenges for societies with rapidly aging populations. Human genetics studies …

Mitochondrial dysfunction in the development and progression of neurodegenerative diseases

J Johnson, E Mercado-Ayon, Y Mercado-Ayon… - Archives of biochemistry …, 2021 - Elsevier
In addition to ATP synthesis, mitochondria are highly dynamic organelles that modulate
apoptosis, ferroptosis, and inflammasome activation. Through executing these varied …

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

YC Wong, D Krainc - Nature medicine, 2017 - nature.com
Alterations in α-synuclein dosage lead to familial Parkinson's disease (PD), and its
accumulation results in synucleinopathies that include PD, dementia with Lewy bodies …

Mitochondrial dysfunction in Parkinson's disease

A Bose, MF Beal - Journal of neurochemistry, 2016 - Wiley Online Library
Parkinson's disease (PD) is the second most common neurodegenerative disease. About
2% of the population above the age of 60 is affected by the disease. The pathological …

β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease

S Mittal, K Bjørnevik, DS Im, A Flierl, X Dong… - Science, 2017 - science.org
Copy number mutations implicate excess production of α-synuclein as a possibly causative
factor in Parkinson's disease (PD). Using an unbiased screen targeting endogenous gene …

Mitochondrial biogenesis in neurons: how and where

C Cardanho-Ramos, VA Morais - International journal of molecular …, 2021 - mdpi.com
Neurons rely mostly on mitochondria for the production of ATP and Ca2+ homeostasis. As
sub-compartmentalized cells, they have different pools of mitochondria in each compartment …

PGC1α in the kidney

MR Lynch, MT Tran, SM Parikh - American Journal of …, 2018 - journals.physiology.org
Acute kidney injury (AKI) arising from diverse etiologies is characterized by mitochondrial
dysfunction. The peroxisome proliferator-activated receptor γ coactivator-1alpha (PGC1α), a …